Results 241 to 250 of about 16,752,750 (355)

Multiplicative functionals and entire functions [PDF]

Studia Mathematica, 1996
openaire   +3 more sources

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Refractive development III: Variations in emmetropia and ametropia. [PDF]

Ophthalmic Physiol Opt
Rozema JJ, Emamian MH, Hashemi H, Fotouhi A.   +3 more
europepmc   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Enhancing reliability and efficiency of flight dynamics systems for planetary exploration through KPLO ground operation experience. [PDF]

Sci Rep
Song YJ, Bang J, Bae J, Hong S, Kim D, Lee D.   +5 more
europepmc   +1 more source

Factorization of entire functions

Tohoku Mathematical Journal, 1975
openaire   +3 more sources

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Multiple subpial transections with concomitant responsive neurostimulation of the insula: illustrative case. [PDF]

J Neurosurg Case Lessons
Ziechmann R, Galligan K, DiGiovine M, Marsh ED, Kennedy BC.   +4 more
europepmc   +1 more source

On the factorization of entire functions

Illinois Journal of Mathematics, 1977
openaire   +2 more sources

On the mean of an entire function and the mean of the product of two entire functions [PDF]

Tohoku Mathematical Journal, 1967
openaire   +3 more sources